1167 related articles for article (PubMed ID: 10803637)
1. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
2. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
3. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
6. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
7. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
8. Cannabis: discrimination of "internal bliss"?
Wiley JL
Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
[TBL] [Abstract][Full Text] [Related]
9. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
Zimmer A; Zimmer AM; Hohmann AG; Herkenham M; Bonner TI
Proc Natl Acad Sci U S A; 1999 May; 96(10):5780-5. PubMed ID: 10318961
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
Sim-Selley LJ
Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
12. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and memory: animal studies.
Castellano C; Rossi-Arnaud C; Cestari V; Costanzi M
Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):389-402. PubMed ID: 14683467
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
15. The effects of cannabinoids on the brain.
Ameri A
Prog Neurobiol; 1999 Jul; 58(4):315-48. PubMed ID: 10368032
[TBL] [Abstract][Full Text] [Related]
16. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization.
Lesscher HM; Hoogveld E; Burbach JP; van Ree JM; Gerrits MA
Eur Neuropsychopharmacol; 2005 Jan; 15(1):31-7. PubMed ID: 15572271
[TBL] [Abstract][Full Text] [Related]
17. Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201.
AlKhelb D; Burke EL; Zvonok A; Iliopoulos-Tsoutsouvas C; Georgiadis MO; Jiang S; Ho TC; Nikas SP; Makriyannis A; Desai RI
Eur J Pharmacol; 2023 Dec; 960():176168. PubMed ID: 38059442
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB
Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
[TBL] [Abstract][Full Text] [Related]
20. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
